Polypropylene or plastic-based wipes, which have been industry standard due to their reliable nature and compatibility with biocidal active materials, are due to be banned in the UK, because they take up to 100 years to break down.
Byotrol says its new wipes are made using a plastic-free 100% biodegradable substrate that deteriorates 3 months after disposal.
The company adds that the new wipes are proven to destroy bacteria, yeast, enveloped viruses, and fungi on non-porous surfaces and are effective against animal-specific pathogens such as: Brucella canis, Streptococcus equi, Staphylococcus aureus, Salmonella typhimurium, Bordetella bronchiseptica, Coronaviruses, Feline Immunodeficiency Virus (FIV), and Microsporum canis and Trichophyton mentagrophytes
Jane Kiely, Head of Marketing at Byotrol said: “Launching the Anigene Professional Surface Disinfectant Wipes is the final step in removing plastic wet wipes from our portfolio and a significant milestone in Byotrol’s sustainability journey.
"We are proud to be at the forefront of sustainability in the veterinary industry, offering an effective and regulatory-compliant product range that meets the needs of our customers”
Byotrol will be on Stand F18 at the London Vet Show.
https://byotrol.com
The event is merging with the new northern VETcpd Congress to give attendees a broader range of CPD subjects.
In the wound management streams, Shelly Jefferies (pictured right) will run a series of workshops on: ‘Wound preparation for optimum healing’, ‘Wound dressing selection’ and ‘Building a better bandage’.
On the first day of the lecture programme, Samantha Bell will be looking at various different aspects and considerations for wound management through all stages, from initial presentation and assessment of the traumatic wound patient, including lavage and debridement techniques, to selection of dressings for open wound management, to surgical closure.
Other speakers in the wound management stream will cover topics such as acute wound management in rabbits and other exotic species, coping with eye problems and what to do and what not to do after oral surgery to allow healing.
Alongside the wound management programme will be two streams for veterinary surgeons – open to nurses as well – with Dr David Williams (ophthalmology), Dr Bob Partridge (dentistry), Dr Molly Varga (rabbits and exotics), Dr Fergus Allerton (antibiotics and immune-mediated diseases), Professor John Innes (orthopaedics), Professor Jon Hall (small animal surgery), Dr Joanne Harris (cardiology), Dr Alison Hayes (oncology), Dr Samantha Lane small animal surgery), Dr Anita Patel (dermatology) and Angie Lloyd-Jones (ultrasound).
On day two, David Williams will conduct an interactive session on ethics in which he will present a series of cases and ask the audience to discuss what they would do in each.
There will also be a series of workshops on ultrasound, covering basic system controls and image optimisation, abdominal ultrasound assessment techniques, and other aspects.
Lastly, there will be a stream specifically for equine practitioners featuring Professor Michael Schramme of the University of Lyon, Dr Alison Talbot of the University of Liverpool, Dr Lesley Young from Newmarket, Dr Gemma Pearson from Edinburgh, David Green from the VDS and Philip Cramo of Hambleton Equine Clinic.
Accommodation is available in the Hilton Garden Inn on-site at £105 per night or £125 per night for double occupancy. This rate is available by emailing HGIreservations@doncaster-racecourse.co.uk, quoting VETcpd.
Early bird two day passes cost £195+VAT for veterinary nurses and £285+VAT for veterinary surgeons, with one day tickets also available.
www.vetcpdcongress.co.uk.
The speakers are:
Dr Lappin said: “There are a number of significant changes in the management of SARS-CoV-2 that impact companion animal medicine and our staff members since our first webinar. I believe the information to be presented will be extremely valuable in helping your veterinary team continue to successfully navigate this pandemic.”
David Sutton, Global Technical Director at webinar sponsors MSD Animal Health, said “COVID-19 has presented an extraordinary challenge to the global community. MSD Animal Health is proud to support WSAVA in providing quality education to veterinary professionals who continue to go above and beyond in the care of companion animals during the pandemic.”
To register for the webinar, visit: http://bit.ly/wsavawebinar-covd19-registration
According to the charity, hens have been badly neglected by the world of evidence-based academic research, with only two known papers written about their welfare.
However, researchers are now starting to take an interest and it is hoped that the new forum, nicknamed The Coop, will pave the way for ground-breaking studies around the world into hen welfare and hen keeping.
Jane Howorth MBE, Founder of the BHWT, said: “The research about to be undertaken ranges from exploring how hens benefit our mental health to seeking good veterinary care and appropriate drugs. They will also examine how the pet hen population has grown over the years and reasons for keeping them, and which homegrown remedies are used and which work.
One of the first bits of research to be supported by the BHWT is a study called ‘From the Backyard to our Beds’ by Jenny Mace BSc, MSc AWSEL, FHEA, Visiting Lecturer on the MSc in Animal Welfare Science, Ethics and Law at the Centre for Animal Welfare at the University of Winchester.
The survey will collect data on the care-taking practices and attitudes towards chickens of non-commercial chicken carers, and you can take part here: https://winchester.onlinesurveys.ac.uk/from-the-backyard-to-our-beds-the-spectrum-of-care-in.
Jenny said: “To my knowledge, this research constitutes the first quantitative study to distinguish between ex-commercial and ‘standard’ chickens. It is also the first to enquire about some niche care-taking practices, such as the use of hormonal implants as a possible means of healthcare in hens.
“The results should be fascinating and I urge all backyard chicken keepers/rescuers to make sure their experiences are captured by filling out this survey. Thank you so much!”
The BHWT is also supporting work undertaken by Keiran Ragoonanan, a student at the Royal Veterinary College in London, who is investigating backyard chicken husbandry and feeding practices in the UK.
For more information visit: https://www.bhwt.org.uk/hen-health/take-part-in-ground-breaking-research-to-help-pet-chickens/
The multicentre observational study described 382 placements of catheters across 19 different institutions, recording the placement techniques and tracking resulting complications to determine the associated risk factors.
The majority of the data was collected by veterinary nurses across the country.
The risk factors identified included the number of insertion attempts, whether a second subsequent placement was required, the frequency that the catheter was flushed and if the flush solution was compound sodium lactate.
In addition to identifying the risk factors, the study also found that complications occurred in just over one-quarter of placements, with limb swelling and phlebitis being the most common (11.5%).
The second most common complication observed was PIVC dislodgement/patient interference (7.9%).
As a result of these findings, the researchers are calling for more vigilant monitoring of patients with a PIVC in situ, particularly if they have experienced any of the factors that increase their risk of complications.
Eleanor said: “PIVCs are placed every day in almost all veterinary practices, yet there is little evidence to inform how best to place and manage them.
"I am passionate about providing the best care for cats and dogs, and it was fantastic to work with like-minded nurses and vets who wanted to gather the evidence that we can use to improve the care of our patients.
"I look forward to continuing this area of research, and believe veterinary nurses are best placed to undertake this work as it is part our of daily working lives."
Dr Christopher Scudder, Senior Lecturer in Small Animal Internal Medicine at the Royal Veterinary College and senior author in the study, said: “The hope is that this study will stimulate more research about PIVCs, and that sufficient evidence will be developed to help reduce complications associated with these routinely placed devices.”
Reference
The survey of 76 vets and nurses, which was conducted by the company in September and October 2024, found that 43% believe that staff wellbeing could be improved within their practice.
It also found that 93% agreed it is important for staff wellbeing to be taken seriously (Ed's note: one wonders what the other 7% think).
The most common strategies were:
NVS, which also sells a range of natural calming products for animals including NVS Select Calming Chews, also asked veterinary professionals how often they encounter nervous or stressed animals.
The answer from 92% of respondents was, perhaps a little unsurprisingly, daily.
82% said they use medications and supplements to support nervous animals.
https://www.nvsweb.co.uk/products/big-chill/
https://www.nvsweb.co.uk/our-brands/select-from-nvs
The offer has been made possible due to the generosity of Baker McVeigh, CVS Equine, IVC Evidensia, Newmarket Equine Hospital, Rossdales, VetPartners and XLVets.
Benefits of the free membership include:
Free student membership is one of several equine vet nurse initiatives introduced by BEVA over the past few months.
Earlier this year, the Association published new Schedule 3 Guidelines designed to support equine veterinary professionals and businesses by describing how equine Registered Veterinary Nurses (eRVNs) are permitted to work.
At its Congress in September, BEVA introduced a Vet Nurse Empowerment Award to highlight the skills and versatility of equine nurses.
It has also increased the amount of CPD it offers vet nurses and started a dedicated stream at BEVA Congress.
Vet nurses also have a direct voice within BEVA via the VN committee.
President David Rendle said: “Historically, equine veterinary nurses have been undervalued in practice but thankfully this is now changing."
“Veterinary nurses have invested huge amounts of time and effort to become highly skilled and it’s great that their talents, versatility and commitment are being supported and celebrated in these ways.”
https://www.beva.org.uk/Join-BEVA/vet-student
Pergocoat contains pergolide, a long-acting dopamine receptor agonist.
It is available in 0.5mg (off-white) and 1mg (yellow) tablets for accurate dosing without the need to split tablets.
The tablets are film-coated to mask the bitter taste of pergolide and create a barrier between the horse owner and the active ingredient.
Available in two different pack sizes containing 60 or 160 tablets, Pergocoat tablets are packaged in double layered blister packs to help minimise the risk of accidental ingestion.
Rachel Addison BVM&S MRCVS, equine field support manager at Dechra said: “Pergocoat is available in two convenient tablet sizes to achieve an optimal treatment response.
"Horses can be monitored and reviewed every four to six weeks until stabilisation or improvement of clinical signs is observed.”
https://www.dechra.co.uk/products/horse/prescription/pergocoat#Pergocoat-0-5mg-60-film-coated-tablets-for-horses.
They say that the free system offers an easy way for veterinary practices to improve client service, streamline workflows, and enhance animal welfare.
Boop uses AI and computer vision to auto-populate vaccination details and capture things like microchip numbers, to ensure certificates are positively identifiable and compliant with the RCVS 10 principles of certification and electronic signing guidance.
Pet owners can then store and access digital vaccination certificates on their mobile phone through the Boop app, where they can also look-up chip details, up to 30% of which are not properly registered.
The app also lets owners share vaccination certificates easily with boarding and day care establishments via email or whatsapp.
Charlie said: “Boop brings a vaccination record service fit for 2025, enabling vets to add more value to their vaccination service and owners to care better for their pet.
"By linking to the microchip, vets can be confident that every record belongs to the right pet—making care safer, more accurate, and more convenient.”
Once signed up, practices can start issuing digital vaccination certificates immediately, without changing their existing PMS or workflows.
www.booppet.app/vets
The 10 minute survey seeks to capture the current level of understanding and feelings around the deployment of AI tools across the veterinary industry.
VetCT says the purpose of the survey is to start some discussion and identify areas where training and support could help veterinary practitioners.
Julien Labruyère, Chief Innovation Officer at VetCT (pictured), said: “AI is here to stay and will increasingly become part of all aspects of veterinary medicine.
"Indeed, it’s vital to help us solve some of the workforce pressures the profession is facing globally.
"We will increasingly be using the outputs of AI tools to inform our clinical decisions, and yet the mechanisms and algorithms can be something of a black box of mystery.
“We want to understand the needs of clinicians in understanding how to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"The results will be published and freely accessible.
"Our hope is to encourage a collaborative effort to support veterinary teams with embracing the full potential of AI, yet also providing the safeguards and education to the clinicians applying this technology to their patients.”
The survey is here: https://bit.ly/VetCT_AI_Survey.
Rodolfo said: “We are the only independent specialist veterinary hospital in the area with the equipment and experience to diagnose and manage neurological issues in pets.
"With a custom-built veterinary hospital and the expertise to help vets get the best results for their patients, we will provide the next level of affordable, specialist care for owners and their pets with the transparency that our independent status enables.
“We will work hand in hand with referring vets, consulting with them on the best approach for their clients and always keep them fully updated on progress as each case unfolds.
"Initially, we are offering neurology services, but we plan to quickly upscale our operations and offer other services like orthopaedics soon.”
Pets suffering from symptoms including seizures, pain, difficulty walking and problems with balance and orientation can be referred.
"Any peripheral nervous system problems and neuromuscular diseases outside the spinal cord area can also be identified and treated.
Rodolfo added: “My focus is on pure collaboration with the vets that refer to us and their owners.
"I’m wholeheartedly motivated by providing the very best service at accessible prices.
"With a focus on communication and compassion – we will always work with the first opinion vet to put the best interests of their clients’ pets first.
www.southeastvetreferrals.com
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/
Speakers include Dr. Cecilia Villaverde, Consultant at Expert Pet Nutrition and Dr. Aarti Kathrani, Senior Lecturer in Small Animal Internal Medicine at the Royal Veterinary College, and there'll be sessions on managing adverse food reactions, incorporating probiotics into clinical practice and acute gastrointestinal disease.
Attendees will also be able to explore strategies to build strong personal and professional client relationships, including how to initiate effective nutrition conversations and resolve potential conflicts.
On the subject of mental well-being, there'll be expert tips and tricks to help veterinary nurses maintain emotional resilience and thrive in their demanding roles.
https://www.vet-center.eu/eu/pro-plan-vet-nurse-symposium
The researchers, from the Dick Vet Equine Hospital, University of Edinburgh, Newcastle University, Istituto Zooprofilattico Sperimentale delle Venezie, and the University of Padova found that affected horses have major abnormalities in the structure of their neuromuscular junctions, microscopic sites of communication between nerves and muscles that are crucial for normal muscle function.
These abnormalities are believed to represent a toxin specific signature, effectively a ‘smoking gun’, for a neurotoxic enzyme termed a phospholipase A2.
Work is now underway to definitively identify the source of the toxin, in the hope that it will lead to novel treatments and improved diagnostics for this devastating disease.
The researchers think the toxin is likely to be produced by a microbe such as a bacterium or fungus growing on the horse’s pasture during the cold and dry weather which commonly precedes the disease.
Neurotoxic phospholipase A2 toxins are also present in the venom of many poisonous snakes, and there are many similarities between the signs of grass sickness and those of snake envenomation.
While there is no suggestion that venomous snakes cause grass sickness, it is hoped that some of the drugs that are currently being developed to treat and promote nerve regeneration in people paralysed by snake venoms can aid recovery of horses from grass sickness.
The researchers say that the neurotoxin most likely also causes the apparently identical diseases (termed animal dysautonomias) which affect cats, dogs, hares, rabbits, llamas, alpacas and sheep, and that their finding contradicts the previous leading hypothesis that grass sickness is a form of botulism.
This breakthrough is summarised in an editorial in the January 2025 issue of the Equine Veterinary Journal (EVJ).
The editorial, by Bruce McGorum and colleagues, looks at the implications of their article 'Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions2".
Bruce said: “Identifying a probable cause of Equine Grass Sickness represents a significant breakthrough.
"We hope that this discovery will lead to novel treatments and improved diagnostics for this devastating condition.
"We are very grateful for the generous support we have received from horse owners, veterinary surgeons, scientists, charities and funding bodies.”
Bruce's editorial is currently available on Early View, free for 12 weeks, and will also be published in the January 2025 print issue of the EVJ.
Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.
The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.
The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.
The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.
The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.
The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.
The Committee found all elements of the charges proven.
The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.
These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.
Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.
The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.
In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.
"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.
"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”
The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.
It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.
It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.
Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.
Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.
"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.
“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.
"The respondent had ample opportunities for reflection before resolving to act as he did.
"This places his acts of dishonesty in the most serious category.
“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.
"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”
www.rcvs.org.uk/disciplinary
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Zoetis, which has a portfolio of drugs for companion animals, including Apoquel, Cerenia, Convenia, Cytopoint, Librela and Simparica, says it will be sharing knowledge with BVNA members via webinars, regional CPD events and the Veterinary Nursing Journal (VNJ), and supporting the 2024 BVNA Congress.
Zoetis says the educational aspect of the partnership was developed after its market research showed that 8 in 10 veterinary nurses were interested in CPD support on the topic of parasiticides.
Louise Longstaff, National Veterinary Manager - Companion Animal, at Zoetis, said: "Veterinary nurses, alongside veterinary care assistants, all play a key role in the ongoing health and welfare of clients’ pets and as the backbone of every practice, they are to be applauded for all that they do.
"We are delighted to be able to announce this new initiative so soon after Veterinary Nursing Awareness Month and are proudly looking forward to delivering to the extended needs of RVNs as a reflection of our recent market research.”
BVNA President Lyndsay Hughes said: “We are delighted to collaborate with Zoetis on this new initiative.
"This partnership fully aligns with our commitment to promote the vital work of veterinary nurses in upholding animal welfare, plus those in wider veterinary care roles.
"We look forward to working together to enhance our offering to BVNA members, across many of our educational activities as an association.”
Photo: BVNA
Sarah qualified from the Royal Veterinary College in 1998, gained an MSc in Clinical Oncology in 2003, the RCVS Certificate in Veterinary Dermatology in 2010 and RCVS Advanced Practitioner status in 2015. She is now the President of the British Veterinary Dermatology Study Group.
Sarah previously ran two dermatology referral services before co-founding Vet-AI, a company working on artificial intelligence and an online consultation service for pet owners, where she is now the Chief Veterinary Officer.
Sarah said: "Many diseases that are primarily non-pruritic often become pruritic when the animal develops secondary bacterial or yeast infection. These cases require a thorough dermatologic history and physical examination and successful treatment very often depends on identification of the underlying cause."
"Providing the right nutrition should also be implemented to ensure optimal levels of nutrients required for skin repair, barrier function and health. I will be including a complete pruritus work up, discussing how diet can be part of the management of this particular condition."
To register for the webinar, visit: https://vetportal.royalcanin.co.uk/cpd/webinar/
Alan, who is MD of the veterinary business consultancy, Vet Dynamics, will be looking at finances, the team, and scoping out a future strategy. The session will provide practical planning tools, strategic advice, and the opportunity to ask questions.
Bayer points to a number of trends which have emerged during lockdown which it says practices must respond to quickly in the post-lockdown recovery.
The company says retailers have reported that internet traffic increased threefold at the start of lockdown and it remains at double the pre-lockdown levels. Direct retail sales of flea and tick products have also increased.
This suggests that owners are becoming more comfortable with buying preventative healthcare products online.
Bayer says there is a business opportunity here for practices. The subscription box market is expected to hit £1 billion by 20222, and one way practices can capitalise on this trend is by offering home-delivered flea, wormer and tick treatments.
Another business opportunity could lie in research by Banfield Pet Hospital among 1,000 US pet owners in which 20% vowed to take their pets ‘more often’ to the vet post-lockdown for preventative care checkups3.
Caroline Braidwood, Regional Business Manager of Bayer Animal Health said: "We know that many veterinary customers have potentially gone elsewhere during the pandemic and vets will need to work hard to win them back. Our webinar will provide tangible insights to ensure that practices can flourish. Whether you’ve worked with Bayer or not, our team of Veterinary Business Managers are here to help. We’re all in this together, and with some planning, we can ensure the veterinary industry continues to grow.”
To book your webinar place, visit: https://event.webinarjam.com/register/46/rk71qav5
A team of three Ofsted inspectors carried out a four-day inspection, reporting that:
Head of centre Jackie Shopland-Reed said: “We are delighted to have regained our outstanding status, in our first full inspection since being graded as Good in 2015.
“It is very rewarding that the inspectors praised the high quality of teaching and the support we provide for apprentices.
"We also received feedback that apprentices enjoy their learning and feel safe and well supported.
"Our strong and effective partnerships with employers were also praised, all of which which makes us very proud.”
https://www.liteltd.co.uk
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.
CharcoPet is a ready-to-use oral gel formulated with 50% activated charcoal and marine-derived polysaccharides.
Forte says Charcopet has a high concentration of activated charcoal per ml, which reduces the volume needed and minimises handling stress.
It's supplied in a 2 x 30ml dial-dose syringes, with each syringe suitable for up to 15 kg bodyweight, used at 2 ml/kg bodyweight orally, repeatable every 4–6 hours if clinically required.
Dr Lucy Chadwick MVB ACIM CMktr MRCVS, Global Partnerships Manager & Head of Technical Services at Forte Healthcare said: “CharcoPet represents a major step forward in veterinary care, offering practitioners a fast, precise, and reliable solution when faced with suspected or confirmed cases of toxin or medication ingestion."
https://fortehealthcare.com/product/charcopet/
During the webinar, which took place earlier this month, senior officers and staff from the College explained the new guidance, what it will mean for the profession, and answered questions submitted by delegates.
The webinar was chaired by RCVS President Dr Melissa Donald MRCVS with a panel comprising Standards Committee Chair Linda Belton MRCVS, RCVS Registrar Eleanor Ferguson, and RCVS Head of Standards Gemma Kingswell.
The webinar included an overview of the main changes, the considerations to take into account when prescribing POM-Vs remotely, the circumstances under which POM-Vs cannot be prescribed remotely, the prescription of antibiotics, antifungals, antiparasitics and antivirals, and how the guidance will be enforced.
Eleanor Ferguson, RCVS Registrar, said: “We have also now published a range of practice-based scenarios to help explain how the new guidance should be followed in various circumstances, and in relation to different species.
"These scenarios cover a variety of different situations, including how the guidance applies to two or more practices with mutual clients, consultancy services and the prescription of long-term controlled drugs.”
A second webinar will be held on Monday 17th July, with priority for those who wanted to attend the June webinar but were not able to do because it was over-subscribed.
www.rcvs.org.uk/undercare
Genitrix has announced the launch of Prilben (benazapril hydrochloride). The product joins its 'Standards' range, created to offer veterinary practices cost-effective versions of frequently used products.
Prilben is indicated for the treatment of congestive heart failure in dogs and for chronic renal insufficiency in cats. It is provided in packs of 14 x 5mg tablets at a veterinary list price of £4.50, which equates to 32p per tablet.
Rob Watkins, Marketing Director at Genitrix, said: "Benazapril hydrochloride is a tried and trusted medicine used in countless practices and homes across the country every day. Prilben offers a win for both practices and pet owners because its pricing structure enables practices to maintain profitability on the product whilst still providing their clients with an economical alternative."
The first product in Genitrix' Standards range, Dormilan, was launched in late 2009 and offers fast-acting sedation and analgesia for dogs and cats.
The two 60-minute interactive sessions are taking place on Wednesday (21st April) at 12.30pm and 6pm, coinciding with the United Nation’s World Creativity and Innovation Day.
Each session will introduce a range of creative techniques that can be used to spur innovation. Different breakout groups will then have various problems to solve and will utilise these techniques to tackle challenges and issues encountered within everyday veterinary practice.
Sophie Rogers, RCVS ViVet Manager, said: "These creativity techniques are a framework for approaching problems, but the key to developing solutions to everyday tasks and problems is learning how to foster and harness the whole team's creative abilities. These workshops will provide the techniques to help you and your team overcome the common barriers to creativity and gain the tools and mindsets needed to break existing patterns and ways of doing things, generate new ideas, and improve creative self-leadership.”
The workshops will be hosted by Gill Stevens (pictured right), the Founding Director of Level Seven, a consultancy that specialises in merging coaching with design thinking methodology as a way to support innovation and team productivity, and Rick Harris, Founder of Customer Faithful, a research-led consultancy, specialising in customer research, proposition design and employee engagement.
Veterinary professionals can sign up to the sessions, which count towards their continuing professional development (CPD) requirement, via the ViVet website at: www.vivet.org.uk/interactive-workshop-on-creative-thinking/